Breast Cancer Foundation NZ
Lumina PET/CT clinical trial
June 2024
Research Partnership Grant
What is the problem and who is affected?
Lobular breast cancer, diagnosed in about 450 New Zealand women each year, is difficult to detect and accurately stage because it grows in thin layers rather than forming a distinct lump. This can lead to patients receiving either too much or too little treatment, increasing the risk of side effects, recurrence, or cancer spread.
What is this research hoping to achieve?
The clinical trial is testing a new PET-CT imaging method using a tracer called FAPI to improve the accuracy of staging lobular breast cancer. Researchers hope it will become the gold standard for assessing disease spread, allowing more personalised treatment and supporting public funding of PET-CT scans for these patients.
Read more here.-
SeptemberResearch Grant
Dedicated breast cancer clinical trial co-ordinator
-
JuneResearch Partnership Grant
Lumina PET/CT clinical trial
-
JuneMāori Breast Cancer Research Leadership Fellow
Addressing the disparities faced by wāhine Māori and Pasifika women affected by breast cancer in Aotearoa New Zealand.